When considering clinical outsourcing strategies, many factors play into finding the right fit for a Functional Service Provider (FSPx) model. While the overall theory of FSPx may be similar, different teams have implemented FSPx into their organization in different ways to best match their needs.
Join this educational webinar where speakers will present the latest market research data and discuss real-life examples of FSPx in large pharmaceutical companies. Webinar attendees will learn how several organizations have picked their FSPx models and how these models have evolved over time to respond to market shifts.
The discussion will also cover detailed components of an FSPx model, such how training of personnel can be handled, the role that IT systems play in auditing and performance measurement, as well as how to manage global regulations as they pertain to various employment models.
Finally, the speakers will explain the differences between input- and output-based models and hybrid combinations, the pros and cons of each delivery approach as well as cost benefit analyses that can help drive key decision points in an effort to balance efficiency, quality and scalability in each unique FSPx journey.
Dan White, BSN, MBA, Vice President, Head of FSPx, Covance
Dan White has over 25 years of experience working in clinical research and is a seasoned and respected leader within the CRO industry. He has held strategic roles within project management, centralized monitoring, clinical operations and central laboratories. He has also been instrumental in delivering creative and dynamic strategies to sponsors and has collaborated to drive unconventional thinking while approaching new and innovative ways for study delivery, focusing on quality and customer satisfaction.Message Presenter
Dawn Williams, PhD, Director, Clinical FSP – Global Operational Lead, Covance
Dawn Williams is a Clinical Research professional with 18 years of experience across Pharma and CRO industry, as well as academia. Dawn has worked with a number of Sponsors including Eli Lilly, Pfizer and Merck across Phase II-IV clinical trials as a CRA in project management, line management and leadership roles. She has worked within the FSP space for over ten years, building on her expertise in multiple FSP delivery models. Dawn holds a BSc with Honors in Applied Biology and a PhD in Neuropharmacology.Message Presenter
Who Should Attend?
- Clinical Outsourcing
- Functional Operations Director
- Pharmacovigilance Personnel
- Clinical Development Director
- Procurement/Outsourcing Management
What You Will Learn
- The role of FSPx as part of a clinical outsourcing strategy
- Ways to optimize and adjust an FSPx model in an evolving environment
- Methods for training and gathering performance metrics
- How to evaluate the cost benefits of different FSPx models
Covance is a business segment of LabCorp, a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. Employing over 21,000 people worldwide, we are the world’s most comprehensive CRO, dedicated to improving health and improving lives.
Covance is a global leader in nonclinical safety assessment, clinical trial testing and clinical trial management services. Our unique perspectives are based on decades of scientific, medical and regulatory expertise. We generate more safety and efficacy data to support drug approvals than any other company, supporting our clients’ complete lifecycle management.
Together with our clients, Covance transforms today’s healthcare challenges into tomorrow’s solutions. Visit us at www.covance.com.